ProfileGDS4718 / 208623_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 98% 85% 97% 97% 90% 92% 96% 97% 97% 97% 97% 96% 92% 94% 96% 96% 93% 93% 93% 98% 97% 96% 97% 97% 94% 97% 92% 97% 95% 93% 92% 98% 97% 93% 93% 95% 98% 97% 74% 96% 92% 92% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.102397
GSM549102patient 115, normal, homogenized [OPG study]11.347898
GSM549104patient 119, normal, homogenized [OPG study]8.533885
GSM549108patient 138, normal, homogenized [OPG study]11.035997
GSM549119patient 077, normal, homogenized [OPG study]10.838397
GSM549133patient 032, cancer, homogenized [OPG study]9.2954690
GSM549139patient 042, cancer, homogenized [OPG study]9.5445492
GSM549099patient 107, normal, homogenized [OPG study]10.720596
GSM549109patient 139, normal, homogenized [OPG study]11.243497
GSM549110patient 046, normal, homogenized [OPG study]11.139397
GSM549114patient 063, normal, homogenized [OPG study]11.355697
GSM549122patient 082, normal, homogenized [OPG study]11.167797
GSM549134patient 033, cancer, homogenized [OPG study]10.393296
GSM549136patient 036, cancer, homogenized [OPG study]9.6445492
GSM549140patient 044, cancer, homogenized [OPG study]10.033494
GSM549111patient 047, normal, homogenized [OPG study]10.826196
GSM549113patient 057, normal, homogenized [OPG study]10.811496
GSM549132patient 031, cancer, homogenized [OPG study]9.6958793
GSM549137patient 038, cancer, homogenized [OPG study]9.6596193
GSM549142patient 047, cancer, homogenized [OPG study]9.175193
GSM549100patient 110, normal, homogenized [OPG study]11.359798
GSM549107patient 135, normal, homogenized [OPG study]11.183697
GSM549115patient 068, normal, homogenized [OPG study]10.970196
GSM549116patient 072, normal, homogenized [OPG study]10.861697
GSM549120patient 078, normal, homogenized [OPG study]10.939597
GSM549131patient 030, cancer, homogenized [OPG study]10.003894
GSM549118patient 074, normal, homogenized [OPG study]10.864797
GSM549129patient 027, cancer, homogenized [OPG study]9.4220892
GSM549123patient 088, normal, homogenized [OPG study]11.239297
GSM549124patient 006, cancer, homogenized [OPG study]9.9487795
GSM549126patient 015, cancer, homogenized [OPG study]9.7498893
GSM549128patient 025, cancer, homogenized [OPG study]9.5704392
GSM549103patient 117, normal, homogenized [OPG study]11.623898
GSM549117patient 073, normal, homogenized [OPG study]11.405797
GSM549138patient 041, cancer, homogenized [OPG study]9.7717793
GSM549141patient 045, cancer, homogenized [OPG study]9.8562993
GSM549130patient 028, cancer, homogenized [OPG study]10.052695
GSM549101patient 111, normal, homogenized [OPG study]11.316398
GSM549105patient 128, normal, homogenized [OPG study]10.799897
GSM549106patient 134, normal, homogenized [OPG study]7.3824474
GSM549112patient 048, normal, homogenized [OPG study]10.798596
GSM549125patient 011, cancer, homogenized [OPG study]9.4062692
GSM549127patient 024, cancer, homogenized [OPG study]9.4773292
GSM549135patient 035, cancer, homogenized [OPG study]9.7041793